Systemic Sclerosis-associated Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis-associated Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease [Phase 2]
Phase 2 study evaluating the efficacy and safety of vixarelimab in idiopathic pulmonary fibrosis and systemic sclerosis-associated interstit…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma.
A completed clinical trial update describes the functional evolution of diffuse infiltrating pneumonia in patients with systemic sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease [Phase 3]
This clinical trial update notes the completion of a Phase 3 study evaluating cyclophosphamide for systemic sclerosis-associated interstitia…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib
A clinical trial update from Taiwan reports long-term outcomes for people with progressive fibrosing interstitial lung diseases who started …
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMF [Phase 3]
Phase 3 clinical trial evaluating a selective JAK inhibitor for interstitial lung disease due to systemic disease and skin tightness in syst…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis [Phase 3]
A Phase 3 trial evaluating the long-term safety of nintedanib in scleroderma-related lung fibrosis has completed and posted results in 2024.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) [Phase 1]
Phase 1 trial studying whether nintedanib affects components of birth-control pills in women with systemic sclerosis-associated interstitial…
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Abituzumab in SSc-ILD [Phase 2]
Phase 2 trial of abituzumab in systemic sclerosis-associated interstitial lung disease was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease [Phase 3]
Phase 3 clinical trial assessing efficacy and safety of pirfenidone in systemic sclerosis-associated interstitial lung disease.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
This clinical trial update covers idiopathic pulmonary fibrosis, focusing on pathogenesis and staging within the SCOR framework for occupati…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough
A completed clinical trial update evaluating the role of gastroesophageal reflux, microaspiration, and cough in scleroderma lung.
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma [Phase 3]
Reports the completion of a Phase 3 trial evaluating tadalafil for systemic sclerosis-associated interstitial lung disease (scleroderma).